Synthetic Biology Market to Reach USD 78.16 Billion by 2034, Growing at a CAGR of 17.2%

The synthetic biology market was valued at USD 16.02 billion in 2024. It is expected to reach USD 78.16 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 17.2% from 2025 to 2034.

Market Preface:
Synthetic biology is an interdisciplinary field of biotechnology that includes engineering the genetic substance of organisms such as bacteria, viruses, plants, yeast, or animals to attain contemporary attributes. It has the possibility to generate handy alterations in crops, enhanced drugs, robust substances, and more productive industrial procedures.

Researchers across several industries have developed and commercialized commodities using synthetic biology. For instance, the technology is presently being used to engineer proteins that can be utilized for sustainable fabrics. Further, cheese, cell-cultured meats, and plant-dependent meat options generated utilizing engineered cells are commercially obtainable in some markets.

Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/synthetic-biology-market/request-for-sample

Key Growth Drivers:
Technological Advancements: The market is notably pushed by ongoing progressions in gene editing technologies, particularly CRISPR technology. These instruments have transformed the accuracy and productivity of genetic researchers to engineer organisms with wanted attributes more efficiently. The National Institutes of Health underscores that such technologies have speeded the advancement of therapeutic applications and agricultural inventions thereby boosting the synthetic biology market demand.

Growing Demand for Bio-Dependent Commodities: There is an escalating consumer and industrial demand for bio-dependent commodities as green options to conventional petrochemical-dependent commodities. Synthetic biology eases the generation of biofuels, biodegradable plastics, and other eco-friendly substances. The World Economic Forum highlights that influencing synthetic biology can confront crucial provocations in manufacturing and agriculture, encouraging a greener and more resilient bio-economy.

Competitive Aspects:
Market players are concentrating on optimizing their offerings by reaching emerging markets and advancing synthetic biology for varied industrial and personal usage. Some of the prominent players operating in the market include:
• Amyris, Inc.
• Bruker Cellular Analysis
• BICO Group AB
• Codexis, Inc.
• Ginkgo Bioworks Holdings, Inc.
• GenScript Biotech Corporation
• Integrated DNA Technologies, Inc.
• Insitro, Inc.
• Novozymes A/S
• Pivot Bio, Inc.
• Twist Bioscience Corporation
• Viridos, Inc.
• Zymergen Inc. (Acquired by Ginkgo Bioworks Holdings, Inc.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/synthetic-biology-market/request-for-discount-pricing

Synthetic Biology Industry Developments:
• In November 2024, Ginkgo Bioworks reached the first milestone in its collaboration with Merck, focused on advancing biologics manufacturing. This achievement resulted in a $9 million payment to Ginkgo and marked a significant step forward in improving production efficiency and yield for biologic therapies.

• In August 2024, Integrated DNA Technologies expanded its synthetic biology portfolio with the launch of rapid genes and major enhancements to its gene synthesis capabilities. These innovations aim to accelerate the development of synthetic biology applications and improve overall efficiency in gene synthesis processes.

Market Segmentation:
The synthetic biology market segmentation is done on the basis of product, technology, application, and region.

By product analysis, the oligonucleotides and synthetic DNA segment held the largest market share in 2024 owing to the growing demand for synthetic DNA synthesis and RNA, which are important in several applications such as gene synthesis, cloning, and molecular diagnostics. The extensive acquisition of these commodities in research and development ventures across biotechnology and pharmaceutical industries additionally fortifies their market position.

By technology analysis, the polymerase chain reaction (PCR) technology segment dominated the market in 2024 due to its extensive application in augmenting DNA sequences has rendered it essential in several fields, including medical research, diagnostics, and the food and beverage industry.

Buy Now:
https://www.polarismarketresearch.com/buy/2199/0

Regional Analysis:
• North America
o US
o Canada

• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific

• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of Middle East & Africa

• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

Browse More Research Reports:
Placenta Market:
https://www.polarismarketresearch.com/industry-analysis/placenta-market

Soft Tissue Sarcoma Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/soft-tissue-sarcoma-treatment-market

Neurothrombectomy Devices Market:
https://www.polarismarketresearch.com/industry-analysis/neurothrombectomy-devices-market

Microbiome Sequencing Services Market:
https://www.polarismarketresearch.com/industry-analysis/microbiome-sequencing-services-market

Capsule Endoscopy Market:
https://www.polarismarketresearch.com/industry-analysis/capsule-endoscopy-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.